Expand OLMA Menu
OLMA MENU

OLMA Latest Press Releases

-- September 2, 2026 --

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- August 31, 2026 --

Olema Oncology to Participate in Upcoming Investor Conferences Globe Newswire 4:30 PM

-- August 13, 2026 --

Olema Oncology Appoints Jason O'Byrne as Chief Financial Officer Globe Newswire 7:00 AM

-- August 10, 2026 --

Olema Oncology Reports Second Quarter 2026 Financial and Operating Results Globe Newswire 4:01 PM

-- August 4, 2026 --

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- July 2, 2026 --

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- June 2, 2026 --

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- June 1, 2026 --

Lilly's Cancer Bombshell Sparks Hunt for the Next Oncology Stock Set to Explode Globe Newswire 9:05 AM

-- May 26, 2026 --

Olema Oncology Announces Clinical Trial Collaboration and Supply Agreement with Bayer to Evaluate OP-3136 in Combination with NUBEQA (darolutamide) in Metastatic Castration-Resistant Prostate Cancer Globe Newswire 7:00 AM

-- May 21, 2026 --

Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting Globe Newswire 5:00 PM

-- May 19, 2026 --

Olema Oncology to Participate in Upcoming Investor Conferences Globe Newswire 4:30 PM

-- May 12, 2026 --

Olema Oncology Reports First Quarter 2026 Financial and Operating Results Globe Newswire 7:00 AM

-- May 4, 2026 --

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- April 29, 2026 --

Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors Globe Newswire 4:01 PM
Market Data Delayed 15 Minutes